Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. Results from the 2014 national survey on drug use and health: detailed tables. Rockville (MD): SAMHSA. Available at: http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2014/NSDUH-DetTabs2014.pdf. Accessed April 15, 2016.
- Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Pharmacogenomics. 2011; 12: 215-233
- Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.J Anal Toxicol. 1995; 19: 18-26
- Pain control in the presence of drug addiction.Curr Pain Headache Rep. 2016; 20: 35
- Analysis of parent synthetic cannabinoids in blood and urinary metabolites by liquid chromatography tandem mass spectrometry.J Anal Toxicol. 2016; 40: 173-186
- Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.J Anal Toxicol. 2013; 37: 642-651
- Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.Pain Physician. 2011; 14: 259-270
- The addictive brain: all roads lead to dopamine.J Psychoactive Drugs. 2012; 44: 134-143
- In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine outflow in the rat brain.J Neurochem. 1988; 51: 1314-1316
- Drug therapy of depression and anxiety disorders.in: Brunton L.L. Lazo J.S. Parker K.L. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th edition. McGraw-Hill, New York2006: 429-459
- Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study.J Psychopharmacol. 2012; 26: 973-981
- The benzodiazepine diazepam potentiates responses of α1β2γ2L γ-aminobutyric acid type A receptors activated by either γ-aminobutyric acid or allosteric agonists.Anesthesiology. 2013; 118: 1417-1425
- Drug design and synthesis of epsilon opioid receptor agonist: 17-(cyclopropylmethyl)-4,5alpha-epoxy-3,6beta-dihydroxy-6,14-endoethenomorphinan-7alpha-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative epsilon opioid receptor.Bioorg Med Chem. 2004; 12: 4133-4145
- Plasticity of NMDA receptor NR2B subunit in memory and chronic pain.Mol Brain. 2009; 2: 1-11
- Drug metabolism.in: Brunton L.L. Lazo J.S. Parker K.L. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th edition. McGraw-Hill, New York2006: 71-91
- Opioid metabolism.Mayo Clin Proc. 2009; 84: 613-624
- Analgesia for the cirrhotic patient: a literature review and recommendations.J Gastroenterol Hepatol. 2014; 29: 1356-1360
- Cocaine-induced chest pain.Clin Lab Med. 2006; 26: 127-146
- Cocaine.in: Flomenbaum N.E. Goldfrank L.R. Hoffman R.F. Goldfrank’s toxicologic emergencies. 8th edition. McGraw-Hill, New York2006: 1133-1147
- MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release.Brain Res. 1990; 510: 97-103
- Drug addiction.N Engl J Med. 2003; 349: 975-986
- Substance use in the perinatal period.Curr Psychiatry Rep. 2015; 17: 91
- Molecular basis of opioid dependence: role of signal regulation by G-proteins.Clin Exp Pharmacol Physiol. 2003; 30: 307-316
- Interpretation of the presence of 6-monoacetylmorphine in the absence of morphine-3-glucuronide in urine samples: evidence of heroin abuse.Ther Drug Monit. 2003; 25: 645-648
- Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content.Forensic Sci Int. 2014; 241: 87-90
- The poppy seed defense: a novel solution.Drug Test Anal. 2014; 6: 194-201
- The use of serum methadone levels in patients receiving methadone maintenance.Clin Pharmacol Ther. 1988; 43: 623-629
- Quantitation of methadone and metabolite in patients under maintenance treatment.J Anal Toxicol. 2014; 38: 660-666
- New drugs of abuse in North America.Clin Lab Med. 2006; 26: 147-164
- Avoid unfavorable consequences: dextromethorphan can bring about a false-positive phencyclidine urine drug screen.J Emerg Med. 2000; 18: 379-381
- Differences between and combinations of opioids re-visited.Curr Opin Anaesthesiol. 2008; 21: 596-601
- Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.Drug Alcohol Depend. 2004; 75: 37-45
- Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration.J Anal Toxicol. 2014; 38: 524-527
- Weight management in obesity - past and present.Int J Clin Pract. 2016; 70: 206-217
- Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan.J Mass Spectrom. 2013; 48: 49-59
- Mechanism of action of benzodiazepines on GABAA receptors.Br J Pharmacol. 2006; 148: 984-990
- Use and abuse of the benzodiazepines.Ther Drug Monit. 1998; 20: 481-489
- Comparison of LC-MS-MS and GC-MS analysis of benzodiazepine compounds included in the drug demand reduction urinalysis program.J Anal Toxicol. 2016; 40: 201-207
- Ketamine, but not phencyclidine, selectively modulates cerebellar GABAA receptors containing α6 and δ subunits.J Neurosci. 2008; 28: 5383-5393
- Pharmacology of sigma (σ) receptor ligands from a behavioral perspective.Curr Pharm Des. 2012; 18: 863-874
- How theories evolved concerning the mechanism of action of barbiturates.Epilepsia. 2012; 53: 12-25
- Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.Am J Ther. 2006; 13: 534-542
- Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.Arch Gen Psychiatry. 2009; 66: 95-105
- The pharmacology of lysergic acid diethylamide: a review.CNS Neurosci Ther. 2008; 14: 295-314
- Synthetic cathinones (“bath salts”).J Emerg Med. 2014; 46: 632-642
- Bath salts and other emerging toxins.Pediatr Emerg Care. 2014; 30: 47-52
- Prescription sleep aid use among adults: United States 2005-2010.CDC, Atlanta (GA)2013 (Available at:)
- Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.Drugs. 1990; 40: 291-313
- The mechanism of action of zopiclone.Eur Psychiatry. 1995; 10: 117s-128s
- Abuse potential of soma: the GABA(A) receptor as a target.Mol Cell Pharmacol. 2009; 1: 180-186
- Alpha2delta ligands, gabapentin, PGB and MGB: a review of their clinical pharmacology and therapeutic use.Expert Rev Neurother. 2016; ([Epub ahead of print])
- Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.Behav Pharmacol. 2016; 27: 215-224
- Population pharmacokinetic modelling of morphine, gabapentin and their combination in the rat.Pharm Res. 2016; ([Epub ahead of print])
- Disproportionality analysis for the assessment of abuse and dependence potential of pregabalin in the French Pharmacovigilance Database.Clin Drug Investig. 2016; 36: 735-742
- Synthetic cannabinoids 2015: an update for pediatricians in clinical practice.World J Clin Pediatr. 2016; 5: 16-24
- Emerging drugs of abuse: current perspectives on synthetic cannabinoids.Subst Abuse Rehabil. 2015; 6: 113-129
Article info
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
